Skip to main navigation
Skip to search
Skip to main content
University of Nottingham Ningbo China Home
Home
Profiles
Research units
Research output
Projects
Prizes
Activities
Press/Media
Impacts
Student theses
Search by expertise, name or affiliation
Risperidone dose for schizophrenia.
Chunbo Li,
Jun Xia
, Jijun Wang
Nottingham China Health Institute
Research output
:
Journal Publication
›
Review article
›
peer-review
23
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Risperidone dose for schizophrenia.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Confidence Interval
100%
Schizophrenia
100%
Risperidone
100%
Randomized Controlled Clinical Trial
100%
Relative Risk
88%
High Dose
66%
Optimal Dose
33%
Adverse Effects
22%
Dose-ranging
22%
Adverse Events
22%
Ultra-low Dose
22%
Clinical Practice
11%
Extracted Data
11%
Fixed Effects
11%
First Episode
11%
Dose-response Relationship
11%
Continuous Data
11%
Low Quality Data
11%
Cochrane
11%
Mid-range
11%
Review Authors
11%
Dichotomous Data
11%
Antipsychotics
11%
People with Schizophrenia
11%
PANSS
11%
Schizophrenia Spectrum Disorders
11%
Weighted Mean Difference
11%
Intention-to-treat
11%
Clinically Meaningful Improvement
11%
Movement Disorders
11%
Acute Exacerbation
11%
Lack of Response
11%
Gastrointestinal Side Effects
11%
Specific Populations
11%
Cardiovascular Effects
11%
Pharmacology, Toxicology and Pharmaceutical Science
Risperidone
100%
Controlled Clinical Trial
100%
Adverse Event
55%
Dose-Response Relationship
11%
Antipsychotic
11%
Typical Antipsychotic
11%
Group Trial
11%
Motor Dysfunction
11%